Komori
Human Metabolome Technologies (6090) · PolicyRestated

Adoption of the revenue recognition accounting standard

First written in FY2022-Q1. 2 of 3 entries say "Restated". Latest entry: FY2022-Q3.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2022-Q32021: 120212022: 22022
Same theme, other companies

The whole theme swung hardest in 2020: 1 of 11 companies on the "Worse" side.

92 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 123 companies compared. The sentences above are computed from all 123.
Full recordFilings, disclosures and news, newest first
  1. FY2022-Q3RestatedAnnual report

    「The company follows the transitional treatment prescribed in the proviso to paragraph 84 of the revenue recognition accounting standard and related standards. The cumulative effect of retrospective application of the new accounting policy before the beginning of the first quarter of the current consolidated fiscal year is added to or deducted from retained earnings at the beginning of the first quarter, and the new accounting policy is applied from that opening balance. However, there was no impact on the beginning balance of retained earnings or on profit or loss for the cumulative third quarter of the current consolidated fiscal year.」

    The company reconfirmed that the revenue recognition accounting standard applied from the first quarter of FY2022 had no impact on the beginning balance of retained earnings or profit or loss for the cumulative third quarter of the current fiscal year.
  2. FY2022-Q2RestatedAnnual report

    「The company follows the transitional treatment prescribed in the proviso to paragraph 84 of the revenue recognition accounting standard and related standards. There was no impact on the beginning balance of retained earnings. There was also no impact on profit or loss for the cumulative second quarter of the current consolidated fiscal year.」

    The company reconfirmed that the revenue recognition accounting standard applied from the first quarter had no impact on the beginning balance of retained earnings or profit or loss for the cumulative second quarter of the current fiscal year.
  3. FY2022-Q1First statedAnnual report

    「We applied the Accounting Standard for Revenue Recognition (ASBJ Statement No. 29, 31 March 2020; the “Revenue Recognition Standard”) and related standards from the beginning of the cumulative first-quarter period, and now recognize revenue at the amount expected to be received in exchange for the promised goods or services when control of those goods or services transfers to the customer.」

    The company applied the revenue recognition accounting standard from the beginning of the first quarter of FY2022 and also applied the alternative treatment allowing revenue to be recognized upon shipment in certain cases for domestic customers. It stated that there was no impact on the beginning balance of retained earnings or on earnings for the quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Adoption of the revenue recognition accounting standard | Human Metabolome Technologies,Inc. (6090) | Komori